Ramsay Générale de [GDS] vs Clariene SE [CLARI] Detailed Stock Comparison

Ramsay Générale de Santé S.A.

EURONEXT
Loading...

Clariene SE

EURONEXT
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Ramsay Générale de Santé S.A. wins in 4 metrics, Clariene SE wins in 13 metrics, with 0 ties. Clariene SE appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Ramsay Générale de Santé S.A. Clariene SE Better
P/E Ratio (TTM) 34.13 9.76 Clariene SE
Price-to-Book Ratio 0.98 0.38 Clariene SE
Debt-to-Equity Ratio 343.06 200.13 Clariene SE
PEG Ratio N/A 11.35 N/A
EV/EBITDA 14.06 10.22 Clariene SE
Profit Margin (TTM) -0.86% 0.03% Clariene SE
Operating Margin (TTM) 2.62% 13.87% Clariene SE
EBITDA Margin (TTM) 2.62% 13.87% Clariene SE
Return on Equity -2.24% 0.23% Clariene SE
Return on Assets (TTM) 1.82% 2.09% Clariene SE
Free Cash Flow (TTM) $550.90M $815.92M Clariene SE
1-Year Return 6.48% 22.87% Clariene SE
Price-to-Sales Ratio (TTM) 0.21 0.26 Ramsay Générale de Santé S.A.
Enterprise Value $4.97B $8.63B Clariene SE
EV/Revenue Ratio 0.93 1.63 Ramsay Générale de Santé S.A.
Gross Profit Margin (TTM) 71.87% N/A N/A
Revenue per Share (TTM) $49 $15 Ramsay Générale de Santé S.A.
Earnings per Share (Diluted) $-0.38 $0.00 Clariene SE
Beta (Stock Volatility) 0.25 0.76 Ramsay Générale de Santé S.A.

Ramsay Générale de Santé S.A. vs Clariene SE Stock Performance Analysis

Loading Price Chart...

GDS
CLARI

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ramsay Générale de Santé S.A.-1.77%6.10%14.60%3.20%25.28%20.99%
Clariene SE-0.50%-4.51%1.01%14.53%14.53%14.53%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ramsay Générale de Santé S.A.6.48%-41.62%-39.95%-7.48%38.89%38.89%
Clariene SE22.87%22.87%22.87%22.87%22.87%22.87%

Performance & Financial Health Analysis: Ramsay Générale de Santé S.A. vs Clariene SE

MetricGDSCLARI
Market Information
Market Cap i€1.10B€1.36B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i199261,803
90 Day Avg. Volume i293416,194
Last Close€11.10€4.00
52 Week Range€8.72 - €11.55€3.27 - €5.51
% from 52W High-3.90%-27.38%
All-Time High€26.10 (Jun 06, 2022)€7.80 (Jun 12, 2023)
% from All-Time High-57.47%-48.72%
Growth Metrics
Quarterly Revenue Growth0.03%0.00%
Quarterly Earnings Growth-0.34%N/A
Financial Health
Profit Margin (TTM) i-0.01%0.00%
Operating Margin (TTM) i0.03%0.14%
Return on Equity (TTM) i-0.02%0.00%
Debt to Equity (MRQ) i343.06200.13
Cash & Liquidity
Book Value per Share (MRQ)€10.44€10.14
Cash per Share (MRQ)€1.89€2.32
Operating Cash Flow (TTM) i€646.40M€1.07B
Levered Free Cash Flow (TTM) i€377.58M€781.67M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i€0.00€0.00

Valuation & Enterprise Metrics Analysis: Ramsay Générale de Santé S.A. vs Clariene SE

MetricGDS (Apr 24, 2026)CLARI (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i34.139.76
Forward P/E iN/A11.35
PEG Ratio iN/A11.35
Price to Sales (TTM) i0.210.26
Price to Book (MRQ) i0.980.38
Market Capitalization
Market Capitalization i€1.10B€1.36B
Enterprise Value i€4.97B€8.63B
Enterprise Value Metrics
Enterprise to Revenue i0.931.63
Enterprise to EBITDA i14.0610.22
Risk & Other Metrics
Beta i0.250.76
Book Value per Share (MRQ) i€10.44€10.14

Financial Statements Comparison: Ramsay Générale de Santé S.A. vs Clariene SE

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGDS (2025)CLARI (2025)
Revenue/Sales i5.24B5.31B
Cost of Goods Sold i1.16B419.17M
COGS % of Revenue i22.1%7.9%
Gross Profit i4.08B4.89B
Gross Margin i77.9%92.1%
Research & Development iN/AN/A
Operating Income (EBIT) i187.40M283.85M
Operating Margin i3.6%5.3%
EBITDA i599.70M1.12B
EBITDA Margin i11.4%21.0%
Pre-Tax Income i-33.40M11.89M
Pre-Tax Income % of Revenue i-0.6%0.2%
Income Tax i1.60M-3.32M
Income Tax % of Revenue i0.0%-0.1%
Net Income (Profit) i-38.10M9.20M
Profit Margin i-0.7%0.2%

Balance Sheet & Liquidity Metrics

MetricGDS (2025)CLARI (2025)
Cash & Equivalents i366.50M784.79M
Total Current Assets i1.31B1.73B
Total Current Assets % of Revenue i24.9%32.6%
Total Current Liabilities i1.62B2.43B
Total Current Liabilities % of Revenue i30.9%45.8%
Long-Term Debt i3.75B6.78B
Long-Term Debt % of Revenue i71.5%127.6%
Total Shareholders Equity i1.18B3.90B
Retained Earnings i-54.10MN/A
Retained Earnings % of Revenue i-1.0%0.0%
Property, Plant & Equipment i2.96B1.96B

Cash Flow Statement Comparison

MetricGDS (2025)CLARI (2025)
Operating Cash Flow i298.50M396.73M
Operating Cash Flow % of Revenue i5.7%7.5%
Capital Expenditures i-135.80M-256.28M
Free Cash Flow i550.90M815.92M
FCF Margin i10.5%15.4%
Debt Repayment i-148.20M-1.08B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGDSCLARI
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i110.36M356.50M
Float Shares i762,347336.56M
% Held by Insiders i59.47%30.77%
% Held by Institutions i39.92%45.17%
% Held by Public i0.61%24.06%

Dividend Analysis & Yield Comparison: Ramsay Générale de Santé S.A. vs Clariene SE

MetricGDSCLARI
Last 12-Month Dividend i€0.00€0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i€0.00€0.08
3-Year Avg Dividend Yield iN/A3.80%
3-Year Total Dividends i€0.00€0.25
Ex-Dividend DateN/AJun 21, 2023